StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) stock

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $41.65MP/E –Yield –

CalciMedica EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

CalciMedica's EPS for the twelve months ending Jun 30, 2026 was -$1.35. For fiscal 2025 it was -$1.97. The highest annual figure on record is -$1.22 in fiscal 2024.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.97–
FY2024Dec 31, 2024-$1.22–
FY2023Dec 31, 2023-$7.66–
FY2022Dec 31, 2022-$111.16–
FY2021Dec 31, 2021-$1.69–
FY2020Dec 31, 2020-$5.25–
FY2019Dec 31, 2019-$33.41–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.45–
Q1 FY2026Mar 31, 2026$0.30–
Q4 FY2025Dec 31, 2025-$0.68–
Q3 FY2025Sep 30, 2025-$0.52–
Q2 FY2025Jun 30, 2025-$0.40–
Q1 FY2025Mar 31, 2025-$0.36-3700.0%
Q4 FY2024Dec 31, 2024-$0.33–
Q3 FY2024Sep 30, 2024-$0.50–
Q2 FY2024Jun 30, 2024-$0.36–
Q1 FY2024Mar 31, 2024$0.01–
Q3 FY2023Sep 30, 2023-$0.82–
Q2 FY2023Jun 30, 2023-$1.11–
Q1 FY2023Mar 31, 2023-$23.43–
Q2 FY2022Jun 30, 2022-$36.55–
Q1 FY2022Mar 31, 2022-$46.13–
Q4 FY2021Dec 31, 2021-$0.41–
Q3 FY2021Sep 30, 2021-$0.38–
Q2 FY2021Jun 30, 2021-$0.36–
Q1 FY2021Mar 31, 2021-$0.54–
Q3 FY2020Sep 30, 2020-$2.52–
Q2 FY2020Jun 30, 2020-$6.79–
Q1 FY2020Mar 31, 2020-$6.61–
Q4 FY2019Dec 31, 2019-$9.26–
Q3 FY2019Sep 30, 2019-$9.30–

More CalciMedica figures

See a number that looks wrong?